Global Botox Revenue Is Nearly 3500 Million USD In 2016
Monday, 12 Nov, 2018
In the last several years, global market of Botox developed rapidly, with an average growth rate of 12.4%. In 2016, global revenue of Botox is nearly 3500 million USD; the actual production is about 18.5 million vials.
The classification of Botox includes 50U, 100U and other, and the sales proportion of 50U in 2016 is about 59.1%. Botox is used for medical and cosmetic. Medical was the largest application segment in 2016, the proportion is about 54.4%.
North America region is the largest supplier of Botox, with a production market share nearly 78.9% in 2016. Europe is the second largest supplier of Botox, enjoying production market share nearly 16.6% in 2016.
North America is the largest sales place, with a sales market share nearly 66.4% in 2016. Following North America, Europe is the second largest sales place with the sales market share of 21.6%. China, Japan and Korea are also important sales regions for the Botox market.
The Botox industry is highly concentrated, there are only six major manufacturers in global, and high-end products mainly come from USA. In the world wide, major manufactures mainly distribute in North America and Europe. The major manufactures are Allergan, Ipsen, Medytox Inc. and Merz Pharmaceuticals; with the development of technology, other companies will have many opportunities
Company mergers and acquisitions, and inter-companies cooperation have occurred for development and growth. As the downstream consumption usually follows with developed and rapid economic growth areas, such as BRICS, the developed areas’ company prefers investing to underdevelopment regions these years. With the global economic recovery, more and more people pay attention to rising environment standards, especially in development of the regions that have a large population and fast economic growth, the need of Botox will increase.